| SpectraBase Spectrum ID |
8HTK1kLR8j2 |
| Name |
1-(3-Trifluoromethylbenzyl)-2-methylpiperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
258.134383044 u |
| Formula |
C13H17F3N2 |
| InChI |
InChI=1S/C13H17F3N2/c1-10-8-17-5-6-18(10)9-11-3-2-4-12(7-11)13(14,15)16/h2-4,7,10,17H,5-6,8-9H2,1H3 |
| InChIKey |
MZMPXCYJKCNVOJ-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
258.288 g/mol |
| Nominal Mass |
258 u |
| Quality |
977 |
| Retention Index |
1972 |
| SMILES |
C(C1=CC(CN2C(CNCC2)C)=CC=C1)(F)(F)F |
| SPLASH |
splash10-0a4i-8790000000-80f40fd8c0d3c7b3ac1c |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(3-trifluoromethylbenzyl)-2-methyl
2-methyl-1-(3-(trifluoromethyl)benzyl)piperazine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011214 |
